1. Tumor-Intrinsic Mechanisms Regulating Immune Exclusion in Liver Cancers
   Katherine E. Lindblad et al, 2021, Frontiers in Immunology CrossRef
2. SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBC
   Meriem Hasmim et al, 2022, Frontiers in Immunology CrossRef
3. Therapeutic Effects of Crocin Alone or in Combination with Sorafenib against Hepatocellular Carcinoma: In Vivo & In Vitro Insights
   Suzan Abdu et al, 2022, Antioxidants CrossRef
4. The current status and future of PD-L1 in liver cancer
   Liyuan Hao et al, 2023, Frontiers in Immunology CrossRef
5. IL-23 amplifies the epithelial-mesenchymal transition of mechanically conditioned alveolar epithelial cells in rheumatoid arthritis-associated interstitial lung disease through mTOR/S6 signaling
   Chujie Zhang et al, 2021, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
6. Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies
   Daniel L. Pouliquen et al, 2022, Frontiers in Pharmacology CrossRef
7. Epithelial–Mesenchymal Transition-Mediated Tumor Therapeutic Resistance
   Zhimin Xu et al, 2022, Molecules CrossRef
8. Application of Immunotherapy in Hepatocellular Carcinoma
   Lele Miao et al, 2021, Frontiers in Oncology CrossRef
9. Tumor Evasion of the Immune System: Role of Interferon and Tumor Necrosis Factor in Cancer
   Rohit Seth et al, 2022, Handbook of Cancer and Immunology CrossRef
10. Cancer Immunotherapy: Diverse Approaches and Obstacles
    Seyed Amir Sanatkar et al, 2022, Current Pharmaceutical Design CrossRef